Free Trial

Option Care Health (OPCH) Competitors

Option Care Health logo
$30.39 -0.35 (-1.14%)
Closing price 04:00 PM Eastern
Extended Trading
$30.63 +0.24 (+0.79%)
As of 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OPCH vs. HIMS, GH, RDNT, BTSG, SHC, SGRY, PRVA, CON, WGS, and VCYT

Should you be buying Option Care Health stock or one of its competitors? The main competitors of Option Care Health include Hims & Hers Health (HIMS), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

Option Care Health vs. Its Competitors

Hims & Hers Health (NYSE:HIMS) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

Hims & Hers Health has a beta of 2.02, meaning that its stock price is 102% more volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by insiders. Comparatively, 0.6% of Option Care Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Hims & Hers Health currently has a consensus price target of $39.58, indicating a potential downside of 23.51%. Option Care Health has a consensus price target of $35.50, indicating a potential upside of 16.81%. Given Option Care Health's stronger consensus rating and higher possible upside, analysts clearly believe Option Care Health is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
3 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.92
Option Care Health
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

Hims & Hers Health has a net margin of 9.24% compared to Option Care Health's net margin of 4.12%. Hims & Hers Health's return on equity of 22.75% beat Option Care Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health9.24% 22.75% 15.51%
Option Care Health 4.12%16.90%7.00%

Option Care Health has higher revenue and earnings than Hims & Hers Health. Option Care Health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.48B7.85$126.04M$0.6975.00
Option Care Health$5.19B0.96$211.82M$1.2424.51

In the previous week, Hims & Hers Health had 71 more articles in the media than Option Care Health. MarketBeat recorded 80 mentions for Hims & Hers Health and 9 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.53 beat Hims & Hers Health's score of 0.28 indicating that Option Care Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
17 Very Positive mention(s)
3 Positive mention(s)
55 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Option Care Health
7 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Hims & Hers Health and Option Care Health tied by winning 8 of the 16 factors compared between the two stocks.

Get Option Care Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPCH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPCH vs. The Competition

MetricOption Care HealthMED IndustryMedical SectorNASDAQ Exchange
Market Cap$4.98B$4.86B$5.57B$9.31B
Dividend YieldN/A1.34%4.23%4.03%
P/E Ratio24.5134.9928.6119.73
Price / Sales0.9689.58412.00173.26
Price / Cash18.6523.1436.0257.96
Price / Book3.684.278.235.67
Net Income$211.82M$189.47M$3.23B$257.79M
7 Day Performance-0.82%-2.09%-0.01%0.52%
1 Month Performance-4.49%-7.12%5.61%8.84%
1 Year Performance-2.69%-4.77%26.52%14.18%

Option Care Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPCH
Option Care Health
4.4957 of 5 stars
$30.39
-1.1%
$35.50
+16.8%
+2.1%$4.98B$5.19B24.518,088Positive News
HIMS
Hims & Hers Health
2.2346 of 5 stars
$48.34
+0.8%
$39.58
-18.1%
+120.8%$10.74B$1.48B111.581,637Trending News
Insider Trade
GH
Guardant Health
4.4811 of 5 stars
$49.54
-1.9%
$53.76
+8.5%
+52.5%$6.26B$739.02M-14.612,021Positive News
Analyst Upgrade
RDNT
RadNet
3.4257 of 5 stars
$55.26
-1.7%
$69.60
+26.0%
-11.5%$4.22B$1.83B-128.5111,021Positive News
BTSG
BrightSpring Health Services
1.747 of 5 stars
$22.00
-0.5%
$24.90
+13.2%
+77.2%$3.89B$11.27B78.5735,000
SHC
Sotera Health
3.1903 of 5 stars
$11.40
-2.9%
$16.00
+40.4%
-6.9%$3.33B$1.10B18.943,000News Coverage
SGRY
Surgery Partners
2.5004 of 5 stars
$22.03
-0.5%
$33.56
+52.3%
-15.2%$2.84B$3.11B-14.4015,000
PRVA
Privia Health Group
3.819 of 5 stars
$21.35
-3.4%
$27.77
+30.1%
+14.9%$2.70B$1.74B184.251,140Positive News
CON
Concentra Group Holdings Parent
2.822 of 5 stars
$20.33
-1.1%
$28.50
+40.2%
N/A$2.64B$1.90B15.1711,250
WGS
GeneDx
3.7807 of 5 stars
$85.74
-6.4%
$90.13
+5.1%
+136.8%$2.61B$305.45M100.671,200Analyst Downgrade
VCYT
Veracyte
3.5735 of 5 stars
$26.34
-4.3%
$40.90
+55.3%
+11.7%$2.15B$445.76M64.25790News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:OPCH) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners